Merck stock holds firm as Keytruda drives revenue growth and late stage pipeline advances

Merck stock holds firm as Keytruda drives revenue growth and late stage pipeline advances  ad-hoc-news.de

Summary aggregated from ad-hoc-news.de's public RSS feed. The full reporting belongs to ad-hoc-news.de — please read it on their site.